Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,381,319 papers from all fields of science
Search
Sign In
Create Free Account
U251
A glioblastoma cell line established from a 75 year old male with glioblastoma.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Retraction Note to: miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3
Weihao Li
,
Hui Huang
,
+4 authors
Hong Wang
Molecular Neurobiology
2017
Corpus ID: 20894405
MicroRNAs are important regulators of multiple cellular processes, and aberrant miRNA expression has been observed in human…
Expand
2016
2016
MicroRNA-206 Inhibited the Progression of Glioblastoma Through BCL-2
W. Hao
,
W. Luo
,
+5 authors
Maode Wang
Journal of Molecular Neuroscience
2016
Corpus ID: 27029497
Gliomas are the most common type of brain tumor and have a poor prognosis. MicroRNAs (miRNAs) are a class of small, endogenous…
Expand
2014
2014
MiR-323-5 p acts as a Tumor Suppressor by Targeting the Insulin-like Growth Factor 1 Receptor in Human Glioma Cells
Haiwei Lian
,
Yunyan Zhou
,
Zhi-Hong Jian
,
Ren Liu
2014
Corpus ID: 46104108
Gliomas are the most common primary brain tumors (Jansen et al., 2010), posing a disproportionately high mortality rate of more…
Expand
2012
2012
Glioma Stem-like Cells are Less Susceptible than Glioma Cells to Sonodynamic Therapy with Photofrin
Zhongye Xu
,
Xiao-qing Li
,
Song Chen
,
Yuan Cheng
,
Jinmu Deng
,
Zhi-gang Wang
Technology in Cancer Research and Treatment
2012
Corpus ID: 36997017
Despite remarkable progress in diagnosis and treatment, malignant glioma, a highly lethal cancer of the central nervous system…
Expand
2011
2011
Early versus late GD‐DTPA MRI enhancement in experimental glioblastomas
P. Farace
,
S. Tambalo
,
+7 authors
P. Marzola
Journal of Magnetic Resonance Imaging
2011
Corpus ID: 7854723
To compare early versus late enhancement in two glioblastoma models characterized by different infiltrative/edematous patterns.
2009
2009
In vitro and In vivo Radiosensitization of Glioblastoma Cells by the Poly ( ADP-Ribose ) Polymerase Inhibitor E 7016
A. Russo
,
Hyuk-ChanKwon
,
+8 authors
K. Camphausen
2009
Corpus ID: 11051165
Purpose: Poly (ADP-ribose) polymerase (PARP) inhibitors are undergoing clinical evaluation for cancer therapy. Because PARP…
Expand
2007
2007
TPI 287 crosses the blood brain barrier and contributes to antitumor activity in the U251 glioblastoma intracranial tumor model in nude mice.
D. Emerson
,
Mark B. Jones
,
C. Bell
,
E. Brown
2007
Corpus ID: 76238550
1441 The treatment of glioblastoma with chemotherapeutic agents is hampered by the inability of most drugs to sufficiently…
Expand
2000
2000
8-Cl-cAMP and tiazofurin affect vascular endothelial growth factor production and glial fibrillary acidic protein expression in human glioblastoma cells
K. Drabek
,
Milica Pešic´
,
+4 authors
L. Rakic´
Anti-Cancer Drugs
2000
Corpus ID: 21262348
Compounds that could block tumor angiogenesis and induce tumor cell differentiation in malignant gliomas represent a very…
Expand
1993
1993
PB-100: a potent and selective inhibitor of human BCNU resistant glioblastoma cell multiplication.
M. Beljanski
,
S. Crochet
,
M. Beljanski
Anticancer Research
1993
Corpus ID: 42353389
Major drawbacks to present-day cancer chemotherapy are its intrinsic lack of selectivity for tumour cells, resulting in severe…
Expand
1985
1985
Studies on the relationship between the radiation resistance and glutathione content of human and rodent cells after treatment with dexamethasone in vitro.
B. C. Millar
,
S. Jinks
International Journal of Radiation Biology and…
1985
Corpus ID: 20593252
A 20 h pre-treatment of human cells from normal (foetal lung) or malignant origin (glioma, lines U118 MG and U251 MG and bladder…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE